These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6892449)

  • 41. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atenolol 50 mg or metoprolol 200 mg - a comparison of antihypertensive efficacy, side effects and lipoprotein changes.
    Weiner L; Rössner S
    Acta Med Scand Suppl; 1983; 677():153-7. PubMed ID: 6367374
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hypotensive effect of ketanserin and evaluation of its alpha-blocking activity].
    Casiglia E; Gava R; Nicolin P; Semplicini A; Rossi GP; Buzzaccarini F; Pessina AC; Dal Palù C
    Cardiologia; 1986 Sep; 31(9):709-14. PubMed ID: 3028631
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
    Bhadada SV; Goyal RK
    Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Non-invasive long-term monitoring of blood pressure and arrhythmias in hypertensive patients treated with metoprolol].
    Palma Gamiz JL; Codina J
    Wien Med Wochenschr; 1988 Jan; 138(1-2):38-40. PubMed ID: 2451359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atenolol and metoprolol once daily in hypertension.
    Scott AK; Rigby JW; Webster J; Hawksworth GM; Petrie JC; Lovell HG
    Br Med J (Clin Res Ed); 1982 May; 284(6328):1514-6. PubMed ID: 6805588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of celiprolol and metoprolol on lipids, fibrinogen and airways function in hyperlipidaemic hypertensives: a randomised double-blind long-term parallel group trial.
    Johnston GD; Vyssoulis G; Feely J; Holden RD; Radley DR
    J Hum Hypertens; 1995 Feb; 9(2):123-9. PubMed ID: 7752174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?
    Nattel S
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):332-3. PubMed ID: 16265553
    [No Abstract]   [Full Text] [Related]  

  • 49. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group.
    Dahlöf B; Hosie J
    Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metoprolol or atenolol for mild-to-moderate hypertension.
    Lyngstam O; Rydén L
    Lancet; 1979 Sep; 2(8143):634. PubMed ID: 90293
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group.
    Hoffmann J
    Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
    Sourgens H; Schmidt J; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparison of the anti-hypertensive effects of combinations of nifedipine retard with acebutolol or atenolol].
    da Costa PS; de Moraes LB; Costa AG
    Arq Bras Cardiol; 1984 Oct; 43(4):279-82. PubMed ID: 6399201
    [No Abstract]   [Full Text] [Related]  

  • 54. [Metoprolol in the treatment of hypertension].
    Mayer O; Rottenborn J; Polívková H
    Vnitr Lek; 1988 Feb; 34(2):130-7. PubMed ID: 3284180
    [No Abstract]   [Full Text] [Related]  

  • 55. ["Slow-release" metoprolol in the therapy of hypertension: comparison with divided doses].
    Pirani R; Buzzetti G; Gruppillo P; Padovan G; Masoni C
    Clin Ter; 1981 Sep; 98(6):627-41. PubMed ID: 7026144
    [No Abstract]   [Full Text] [Related]  

  • 56. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
    Brandão AP; Oigman W; Albanesi Filho FM
    Arq Bras Cardiol; 1981 Dec; 37(6):495-8. PubMed ID: 7347202
    [No Abstract]   [Full Text] [Related]  

  • 58. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension.
    Wheeldon NM; MacDonald TM; Prasad N; Maclean D; Peebles L; McDevitt DG
    QJM; 1995 Aug; 88(8):565-70. PubMed ID: 7648243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
    Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
    Pharmacotherapy; 2006 Sep; 26(9):1247-54. PubMed ID: 16945046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.